Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 2;6(1):46.
doi: 10.1186/s41256-021-00231-1.

Can Africa achieve herd immunity?

Affiliations
Review

Can Africa achieve herd immunity?

Don Eliseo Lucero-Prisno 3rd et al. Glob Health Res Policy. .

Abstract

The World Health Organization described herd immunity, also known as population immunity, as the indirect fortification from an infectious disease that happens when a population is immune either through vaccination or immunity developed through previous exposure to infection. The emergence of COVID-19 vaccine is a step towards the achievement of herd immunity. Over one billion people across the globe have been vaccinated and Africa recorded only 2%. The objective of this article was to develop a forecast of the number of people to be vaccinated to achieve herd immunity in the 13 WHO-identified priority African countries for COVID-19. Herd immunity is achieved when one infected person in a population causes less than one secondary case on average, corresponding to the effective basic reproduction number (R0). Vaccine delivery and distribution infrastructure including the cold chain remains weak. Vaccine hesitancy is also one of the limiting factors that may hinder herd immunity in Africa. In order to achieve herd immunity globally, African countries should not be excluded in fair and equal distribution of vaccines. Relevant stakeholders should foster commitment as well as community sensitization on COVID-19 vaccines and integration of COVID-19 vaccines in existing healthcare services.

Keywords: Africa; COVID-19; Herd immunity; Vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests. Don Eliseo Lucero-Prisno is the Deputy Editor in Chief of Global Health Research and Policy. Hao Li is the Editor in Chief of Global Health Research and Policy. Both of them were not involved in the review of decision related to the manuscript.

Similar articles

Cited by

References

    1. Park KS, Sun X, Aikins ME, Moon JJ. Non-viral COVID-19 vaccine delivery systems. Adv Drug Deliv Rev. 2021;169:137–151. doi: 10.1016/j.addr.2020.12.008. - DOI - PMC - PubMed
    1. Kaye AD, Okeagu CN, Pham AD, et al. Economic impact of COVID-19 pandemic on healthcare facilities and systems: international perspectives. Best Pract Res Clin Anaesthesiol. 2020 doi: 10.1016/j.bpa.2020.11.009. - DOI - PMC - PubMed
    1. Ogunkola IO, Imo UF, Obia HJ, Okolie EA, Lucero-Prisno Iii DE. While flattening the curve and raising the line, Africa should not forget street vending practices. Health Promot Perspect. 2021;11(1):32–35. doi: 10.34172/hpp.2021.05. - DOI - PMC - PubMed
    1. Population Reference Bureau. International Data. Accessed 03 May 2021.
    1. Lucero-Prisno DE, Ogunkola IO, Imo UF, Adebisi UA. Who will pay for the COVID-19 vaccines for Africa? Am J Trop Med Hyg. 2021;104(3):794–796. doi: 10.4269/ajtmh.20-1506. - DOI - PMC - PubMed

Substances